发明名称 OXO-SUBSTITUTED COMPOUNDS, PROCESS OF MAKING, AND COMPOSITIONS AND METHODS FOR INHIBITING PARP ACTIVITY
摘要 Compound, compositions containing compounds, methods of using compounds, and processes of making compounds, of formula (I) containing at least one ring nitrogen, or a pharmaceutically acceptable base or acid addition salt, hydrate, ester, solvate, prodrug, metabolite, stereoisomer or mixtures thereof, wherein: X is double-bonded oxygen, or -OH; when R7 is present, it is hydrogen or lower alkyl; y represents the atoms necessary to form a fused mono, bi- or tricyclic, carbocylic or heterocyclic ring, wherein each individual ring has 5-6 ring member atoms; and Z is (i) -CH2CHR3- wherein R2 and R3 are independently hydrogen, alkyl, aryl or aralkyl; (ii) -R6C=CR3- wherein R3 and R6 are independently hydrogen, lower alkyl, aryl, aralkyl, halo, -NO2, -COOR7, or -NR7R8 where R8 is independently hydrogen or C1-C9 alkyl, or R6 and R3, taken together, form a fused aromatic ring, wherein each individual ring has 56 ring members; (iii) -R2C=N-; (iv) -CR2(OH)-NR7; or (v) -C(O)-NR7-.
申请公布号 CA2294118(A1) 申请公布日期 1999.03.11
申请号 CA19982294118 申请日期 1998.09.02
申请人 GUILFORD PHARMACEUTICALS INC. 发明人 ZHANG, JIE;LI, JIA-HE;TAYS, KEVIN L.
分类号 C07D243/14;A61K31/435;A61K31/4355;A61K31/436;A61K31/4365;A61K31/437;A61K31/4375;A61K31/472;A61K31/502;A61K31/5025;A61K31/5365;A61K31/5383;A61K31/5513;A61K31/553;A61P35/00;A61P43/00;C07D217/22;C07D217/24;C07D217/26;C07D221/04;C07D221/12;C07D221/18;C07D237/30;C07D237/32;C07D237/34;C07D239/88;C07D239/93;C07D239/94;C07D267/14;C07D471/04;C07D471/06;C07D475/02;C07D487/04;C07D491/04;C07D491/048;C07D491/052;C07D495/04;C07D495/14;C07D498/04;C07D498/14;C07D513/04;C07F9/6561;(IPC1-7):C07D221/12;C07D221/16;A61K31/47 主分类号 C07D243/14
代理机构 代理人
主权项
地址